Literature DB >> 26103132

New developments in the pathogenesis of obesity-induced hypertension.

Vasilios Kotsis1, Peter Nilsson, Guido Grassi, Giuseppe Mancia, Josep Redon, Frank Luft, Roland Schmieder, Stefan Engeli, Stella Stabouli, Christina Antza, Denes Pall, Markus Schlaich, Jens Jordan.   

Abstract

Obesity is a disorder that develops from the interaction between genotype and environment involving social, behavioral, cultural, and physiological factors. Obesity increases the risk for type 2 diabetes mellitus, hypertension, cardiovascular disease, cancer, musculoskeletal disorders, chronic kidney and pulmonary disease. Although obesity is clearly associated with an increased prevalence of hypertension, many obese individuals may not develop hypertension. Protecting factors may exist and it is important to understand why obesity is not always related to hypertension. The aim of this review is to highlight the knowledge gap for the association between obesity, hypertension, and potential genetic and racial differences or environmental factors that may protect obese patients against the development of hypertension and other co-morbidities. Specific mutations in the leptin and the melaninocortin receptor genes in animal models of obesity without hypertension, the actions of α-melanocyte stimulating hormone, and SNS activity in obesity-related hypertension may promote recognition of protective and promoting factors for hypertension in obesity. Furthermore, gene-environment interactions may have the potential to modify gene expression and epigenetic mechanisms could also contribute to the heritability of obesity-induced hypertension. Finally, differences in nutrition, gut microbiota, exposure to sun light and exercise may play an important role in the presence or absence of hypertension in obesity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26103132     DOI: 10.1097/HJH.0000000000000645

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  31 in total

Review 1.  Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension.

Authors:  Thierry H Le Jemtel; William Richardson; Rohan Samson; Abhishek Jaiswal; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2017-02       Impact factor: 5.369

Review 2.  The obesity paradox: is it really a paradox? Hypertension.

Authors:  Alessandro Lechi
Journal:  Eat Weight Disord       Date:  2016-11-04       Impact factor: 4.652

3.  Comparison Among Recommendations for the Management of Arterial Hypertension Issued by Last US, Canadian, British and European Guidelines.

Authors:  Christina Antza; Ioannis Doundoulakis; Stella Stabouli; Vasilios Kotsis
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-11-01

Review 4.  Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.

Authors:  Luca Miele; Valentina Giorgio; Maria Adele Alberelli; Erica De Candia; Antonio Gasbarrini; Antonio Grieco
Journal:  Curr Cardiol Rep       Date:  2015-12       Impact factor: 2.931

5.  Comparison of body mass index, waist circumference, conicity index, and waist-to-height ratio for predicting incidence of hypertension: the rural Chinese cohort study.

Authors:  Xu Chen; Yu Liu; Xizhuo Sun; Zhaoxia Yin; Honghui Li; Kunpeng Deng; Cheng Cheng; Leilei Liu; Xinping Luo; Ruiyuan Zhang; Feiyan Liu; Qionggui Zhou; Chongjian Wang; Linlin Li; Lu Zhang; Bingyuan Wang; Yang Zhao; Junmei Zhou; Chengyi Han; Hongyan Zhang; Xiangyu Yang; Chao Pang; Lei Yin; Tianping Feng; Jingzhi Zhao; Ming Zhang; Dongsheng Hu
Journal:  J Hum Hypertens       Date:  2018-02-07       Impact factor: 3.012

Review 6.  Anti-Inflammatory Effects of Melatonin in Obesity and Hypertension.

Authors:  Natalia Jorgelina Prado; León Ferder; Walter Manucha; Emiliano Raúl Diez
Journal:  Curr Hypertens Rep       Date:  2018-05-09       Impact factor: 5.369

Review 7.  Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications.

Authors:  Jun Ren; Ne N Wu; Shuyi Wang; James R Sowers; Yingmei Zhang
Journal:  Physiol Rev       Date:  2021-05-05       Impact factor: 37.312

8.  Alpha-melanocyte-stimulating hormone during exercise recovery has prognostic value for coronary artery disease.

Authors:  Dejana Vidojevic; Stefan Seman; Ratko Lasica; Milorad Tesic; Marija Saric Matutinovic; Snezana Jovicic; Svetlana Ignjatovic; Ross Arena; Svetozar Damjanovic; Dejana Popovic
Journal:  Hormones (Athens)       Date:  2021-02-01       Impact factor: 2.885

9.  Does leisure-time physical activity attenuate or eliminate the positive association between obesity and high blood pressure?

Authors:  André O Werneck; Adewale L Oyeyemi; Aline M Gerage; Edilson S Cyrino; Célia L Szwarcwald; Luís B Sardinha; Danilo R Silva
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-04-25       Impact factor: 3.738

10.  Human amniotic mesenchymal stem cells-conditioned medium protects mice from high-fat diet-induced obesity.

Authors:  Hui-Lan Tan; Xiao-Hui Guan; Min Hu; Jie Wu; Rong-Zhen Li; Ling-Fang Wang; Hou-Da Huang; Zhen-Ping Yu; Xiao-Yu Wang; Yun-Fei Xiao; Ke-Yu Deng; Hong-Bo Xin
Journal:  Stem Cell Res Ther       Date:  2021-06-26       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.